Joinn Laboratories (06127): Shareholder Gu Xiaolei and its concerted action person Gu Meifang intend to reduce their A-share holdings.

date
19:46 16/03/2026
avatar
GMT Eight
Zhao Yan New Medicine (06127) announced that shareholders Gu Xiaolei and their concerted action person Gu Meifang plan to reduce their shareholdings through centralized bidding on the Shanghai Stock Exchange within 3 months after 3 trading days from the date of this reduction plan announcement. The specific reductions are 20,420,500 shares and 10,322,000 shares respectively, totaling 30,742,500 shares, accounting for 4.1026% of the company's current total share capital.
Joinn Laboratories (06127) issued an announcement that shareholders Gu Xiaolei and their concerted action person Gu Meifang intend to reduce their holdings by 20,420,500 shares and 10,322,000 shares through centralized bidding on the Shanghai Stock Exchange within 3 months after the announcement date of the reduction plan, totaling 30,742,500 shares, accounting for 4.1026% of the company's current total share capital.